When used as a screening procedure, ultrasound examination of the fetal urinary tract seldom leads to beneficial interventions. There is also a cost in terms of parental anxiety and unnecessary investigation and treatment. A formal screening programme would therefore be unjustified. However, screening of women for obstetric purposes will continue to reveal fetal abnormalities, and a strategy for dealing with these is needed. Antenatal treatments remain experimental; for most of the common conditions postnatal treatment has no urgency; and, in cases of minor abnormality detected by ultrasound, the best course may be to do nothing.
INTRODUCTION
The fetal urinary tract was first displayed by ultrasound in the late 1960s and the first pathological abnormality was reported in 1970 1 ,2, In a multicentre study the incidence of renal anomalies detected by antenatal ultrasound was estimated at 0.62% of deliveries and at least 65% of these would not have been clinically detectedb". Antenatal ultrasound may therefore have potential as a screening tool:
'to ident~' y unrecognized disease or risk of disease by investigat on that does not arise from a patient's request for medical ai ;,5.
Antenatal ultrasound is now generally accepted as an obstetric screening tool but is also being used to screen the urinary tract 6 ,7. For any screening programme we must be sure that the benefit outweighs any possible harm of the screening procedure or treatment. Strict evaluation must always precede the introduction of a screening services. It is far. from clear that screening of the fetal urinary tract has been subjected to the strict evaluation criteria required. The potential for harm has been emphasized by many authors: atypical findings can cause intense anxiety and distress and inaccurate diagnosis can lead to inappropriate counselling and treatment4,6,9~11.
If screening of the fetal urinary tract meets the criteria in Table 1 , then we can assume that it increases the sum of human happiness. How does it match up to the criteria?
NATURAL HISTORY OF DISEASE
Mild dilatation of the fetal kidney is the commonest abnormal antenatal finding. Possible explanations include 'flow uropathy', low grade or transient pelvi-ureteric Department of Paediatric Nephrourology, Southampton General Hospital, Tremona Road, Southampton S09 4XV, England junction obstruction (PUJ) or a simple variant of normal anatomy such as an extra renal pelvis. The natural history of mild dilatation is becoming increasingly clear. In the early years dilatation of the pelvi-caliceal system was thought to represent PUJ and a large number of patients underwent surgical intervention for the presumed obstructiont-'". Ransley et al. proposed that there was no indication for immediate postnatal surgery, with only 23% of patients eventually needing a pyeloplasty for decrease in function 13.
Further studies supported these views and non-operative management was proposed for patients with normal function 14,15. The Department of Urology at The Hospitals for Sick Children, Great Ormond Street, conducted a randomized controlled trial comparing surgery and conservative management for patients with antenatally diagnosed PUJ16. Of the 32 patients in the conservative arm, 26 (81%) improved or remained stable while only six (19%) required surgery for reduced function. This and some other studies have now identified the criteria likely to lead to surgical intervention'<!". These include: an anteroposterior (AP) renal pelvis diameter > 20 mm; dilatation of the calices; increasing dilatation; reduced function «40%); and an obstructive curve on diuresis renography. Thomas et al.
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studied patients with an AP renal pelvis diameter ranging from 5-15 mm 17. During a cumulative follow-up totalling 122 years there were only two documented episodes of urological morbidity. They concluded that mild dilatation was of doubtful significance and invasive investigation was not justified. They went on to suggest that mild dilatation should no longer be reported as an abnormality, to reduce parental anxiety and prevent unnecessary investigation. It would seem from these data that only a small proportion (approximately 25%) of patients with an antenatally diagnosed hydronephrosis benefit from the diagnosis, which causes considerable anxiety to many parents.
Similar findings are reported for the antenatally diagnosed non-refluxing megaureter 19 -21. With conservative management the dilatation resolved in 34%, remained stable in 49% and in only 17% required surgery (UTI in 5%; reduced function in 12%)20. The criteria associated with the need for surgical intervention were: reduced function ureteric diameter> 10 mm; and poor drainage on excretory renography. It is again obvious that only a small proportion of patients benefited from the antenatal diagnosis and most remained stable or improved spontaneously.
Another condition frequently diagnosed antenatally is the multicystic dysplastic kidney (MCK) with an incidence of 1/4500 live births 7 . The vast majority of these would have been unrecognized in the past. With conservative management partial or complete involution occurs in more than 50% and those that do not involute are usually the larger lesions that would have been palpable anyway22,23. Most experts now advocate conservative management and the practice of 'prophylactic' nephrectomy has virtually been abandoned 17,22-24. This approach raises the question of the risks of leaving the MCK in situ. There have been only three cases of hypertension and six cases of malignancy recognized in the world literature over 20 years, a minute risk compared to the true incidence of the anomaly and certainly not justification for routine nephrectornv". The main significance of the diagnosis would seem to rest in the recognition of associated anomalies, particularly vesicoureteric reflux (VUR) that occurs in over 30% of cases 23 . Some have argued that in the majority of cases reflux is only of a minor degree and its recognition is of no benefit to the patient 23.
From these examples it seems that the natural history of most urinary tract conditions detected antenatally is benign and only a small minority of patients benefit from their recognition.
EFFECTIVE EARLY TREATMENT
The antenatal diagnosis of hydronephrosis led to the rapid development of methods for in utero relief of obstruction, in the hope that renal dysplasia could be prevented and normal renal function preserved. Initial approaches entailed the use of nephro-/vesico-amniotic catheter shunts. In 1986 the International Fetal Surgery Registry reported experience with shunting in 73 fetuses 25. There was a procedure-related death rate of 4.6% and a survival rate of 41%. It was concluded that although the outcome was encouraging for selected fetuses with posterior urethral valves (PUV), it was impossible to establish the efficacy of the procedures because of selection bias. The need for a controlled trial was stressed, but none has yet been reported. In a further survey of 57 cases, shunt placement was unsuccessful in 18%: there was a complication rate of 44%, largely consisting of shunt migration and unsatisfactory drainage; survival in those with oligohydramnios was only 21%26. Improvement in renal function was not clearly demonstrated in any case. More recently, Harrison and Adzick reported their experience with open fetal surgery for hydroncphrosis/". Following their strict selection criteria only seven of more than 200 cases referred were deemed appropriate for open surgery: three survived pregnancy and delivery; one with normal renal function died at 9 months of age; one had normal renal function at 3 years of age; and the third required a renal transplant before the age of 3 years. No larger or more recent series has been reported. Fctoscopic surgery is now being used in experimental animals and this may offer a safer approach to the fetus in the future, but no detailed results are available yet 28 . To summarize, fetal intervention has not been shown to improve long-term renal function. Pulmonary function may be improved in selected cases with severe oligohydramnios 7 . All forms of fetal intervention remain experimental and none should be offered as a standard scrvice/". Another approach to management would be the induction of premature labour to allow early definitive correction of the anomaly. There is no evidence to support this approach and in cases of pulmonary hypoplasia premature delivery may worsen the urinary deficit?
The remaining antenatal optIOn is termination of pregnancy. The ability to counsel patients about long-term prognosiS has been enhanced by the recognition of various prognostic criteria. Adverse prognostic criteria include: moderate/severe oligohydramniOS, echogenic/cystic kidneys and poor fetal urine 30. The urine parameters indicating a poor prognosis are: sodium > 100 mmoll ml; chloride >90mmoll ml; osmolarity >210mOsm; and urine output < 2 ml/h. Urine sampling to assess prognosis is the only definite indication for fetal intervention.
Early postnatal intervention and management may be valuable in selected patients. Prophylactic antibiotics are empirically used in many centres and it is possible that morbidity and renal scarring has been reduced by their use but there are no controlled trials. The early treatment of PUV almost certainly reduces morbidity from urinary tract infection but there is little evidence to suggest a long-term improvement in renal function. In 1993 Dinneen et aI. found that renal function was better in patients diagnosed antenatally but the numbers were too small to draw any conclusions-l. There are other studies showing a worse prognosis for those diagnosed antenatally and Jee et aI. in 1993 suggested that less than 20% of patients benefited from an antenatal diagnosis 32 ,33. There are isolated reports of antenatal diagnosis improving the outcome for patients with rarer anomalies such as megacystis-megaureter and renal duplications by allowing treatment before infection or persistent obstruction worsens the prognosis34, 35 .
In general it is difficult to demonstrate any clear benefit of early treatment in the common conditions diagnosed antenatally.
ACCEPTABILITY OF TREATMENT
There is little doubt that postnatal intervention is accepted by most patients. By contrast, the long-term effects of termination of pregnancy are unresolved. There are no data on the effects of termination for urinary tract anomalies but there are some data on the effects of 'genetic' terrnination v. In 1981 Donnai et aI. stated that persistent adverse psychological and social reactions were much commoner in patients undergoing 'genetic' rather than 'social' terminationts, They stressed the need for counselling and support borh before and after termination. In a further study of 20 therareutic abortions long-term psychological effects were identified 37. These included reactive depression, negative effect on relationship with partner, guilt feelings, regret, shame and a decrease in self confidence. They compared the response to termination to that of accepting a malformed child at birth. Two further large reviews stated that adverse effects occurred in the minority of women on long-term follow-up but there were greater problems when termination was for medical reasons 38,39. Both papers emphaSized the need for better methodology and more controlled studies.
VALIDITY OF SCREENING TESTS
The accuracy of scanning has improved considerably in recent years and we are seeing fewer false positives. However, the false negative rate for significant uropathies is disappointing. Antenatal ultrasound performed prior to 24 weeks' gestation detected only 8.6% of PUV but when a scan was performed after 24 weeks 89% were detected'". Scans after 24 weeks are not routinely performed. Other series report similar negative findings and until scans are routinely performed later in pregnancy it is unlikely that the pick-up rate will be increased 32 ,33,40. The pick-up of significant VUR is similarly disappointing. In one study reflux of grade 3 and greater was missed in 36% of cases and subsequent studies have demonstrated similar findings and suggest that antenatal ultrasound is of little value for vesicoureteric reflux I7,41. Smellie et al. reported 32 children with renal scarring secondary to infection and VUR and only one had an abnormality detected on antenatal scanning42. In a similar type of study, Rickwood et aI. reported 43 patients who presented clinically with PUJ obstruction''. Seven had antenatal scans before 30 weeks' gestation and all were normal; 25 had a scan at or later than 30 weeks and in 20 cases it was completely normal. Antenatal ultrasonography has evident limitations in detecting the most significant obstructive uropathies of childhood (PUVs and PUn and VUR the commonest risk factor for recurrent urinary infection and renal scarring. It is noteworthy that postnatal ultrasound screening for urinary malformations demonstrated pronounced anomalies in 1.04% and mild renal pelvis dilatation in 4.6% of casest", This incidence far exceeds the 0.62% reported for antenatal scanning 3. The occurrence of congenital urinary anomalies on autopsy is approximately 4.6%, so many significant anomalies are probably being missed on antenatal scanning 45.
DISCUSSION
Antenatal ultrasound is an acceptable investigation for the majority of pregnant women and resources are already in place. On present evidence, however, screening of the fetal urinary tract is not to be recommended. Although many anatomical variations have been identified there is no evidence that this has been of long-term benefit. Antenatal screening of the fetal urinary tract has failed the screening evaluation test and has not improved the sum of human happiness. If the procedure was being performed solely to identify fetal uropathy it would now be abandoned. However, antenatal ultrasound will continue to be used for obstetric reasons and it is unrealistic to expect practitioners to ignore the urinary tract. We will continue to be presented with abnormalities of the fetal urinary tract and it is vitally important that we are prepared to manage these patients correctly. We can only do this by careful assessment of the natural history of the various anomalies and with the appropriate evidence educate our colleagues in other fields to avoid unnecessary investigation and treatment.
If we are to achieve these goals, a multidisciplinary approach to the fetus is an essential part of antenatal screening. In many instances minor variations in anatomy should not be reported and certainly not investigated further. In other cases the parents should be counselled on the benign nature of the problem and the baby should be subjected to as little invasive investigation as possible. Antenatal intervention should only be undertaken as part of a well established programme (if at all) and there is no place
